Protara Therapeutics, Inc.
TARA
$3.97
$0.030.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.67M | -17.78M | -17.31M | -13.26M | -14.96M |
| Total Depreciation and Amortization | 72.00K | 90.00K | 93.00K | 88.00K | 98.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50M | 1.46M | 995.00K | 924.00K | 804.00K |
| Change in Net Operating Assets | 4.70M | -5.11M | -731.00K | -206.00K | 1.81M |
| Cash from Operations | -15.39M | -21.34M | -16.95M | -12.45M | -12.25M |
| Capital Expenditure | -332.00K | -- | -24.00K | -4.00K | -22.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.09M | -14.72M | -26.88M | -6.50M | -47.70M |
| Cash from Investing | 17.75M | -14.72M | -26.91M | -6.51M | -47.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.94M | 81.18M | -- | 8.00K |
| Repurchase of Common Stock | -26.00K | -272.00K | 0.00 | -201.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -526.00K | -214.00K | 214.00K | 0.00 |
| Cash from Financing | -26.00K | 1.14M | 80.96M | 13.00K | 8.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.34M | -34.92M | 37.11M | -18.95M | -59.97M |